Pay in 4 interest-free payments of $7.31 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
Scorecard: strongest in Clinical Quality (5.0/5) and Support (5.0/5)
What the Clinical Trial Data Shows for Retatrutide Phase 2 clinical trial results, published in the New England Journal of Medicine, demonstrated that retatrutide produced mean body weight reductions of 17.5% at the 4mg dose and 24.2% at the 12mg dose over 48 weeks in adults with obesity [8]
No formal lifting restrictions exist for GLP-1 medications
GLP-1 analoglar ncelikle tip 2 diyabet ve obezite iin kullanlr, ancak dier metabolik ve hormonal durumlarda da kullanm aratrlmakta veya etiket d olarak kullanlmaktadr
US$ 23.74
US$ 23.93
US$ 26.88
US$ 28.35
